A Multicenter Randomized Controlled Trial Evaluating the Efficacy of Elobixibat Hydrate in Preparing Patients with Chronic Constipation for Colonoscopy

未提供0 个研究点目标入组 192 人开始时间: 待定

适应症

试验速览

暂无简介。

•Patients scheduled to undergo colonoscopy
•Patients aged 18 years or older at the time of consent acquisition
•Individuals for whom written informed consent for participation in this study can be obtained
•Patients diagnosed by a physician with chronic constipation who meet two or more items of the ROMA-IV criteria for constipation and are in a chronic state

•Patients already taking Goofice
•Patients with suspected gastrointestinal obstruction or intestinal obstruction
•Patients with suspected intestinal perforation, gastric stasis, or toxic megacolon
•Patients with inflammatory bowel disease
•Patients who have undergone ileocecal resection or total colectomy
•Women who are pregnant or may be pregnant, women who are breastfeeding, or women who wish to become pregnant
•Patients with a history of hypersensitivity to Goofice, picosulfate sodium, or any component of Moviprep
•Other patients deemed ineligible for enrollment in this study by the principal investigator or sub-investigator

发起方

未提供